Singapore legislation
Regulation 58
of Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021
Regulation 58
Confidential information
For the purposes of section 66(2)(d) of the Act, the Authority may disclose any confidential information relating to the quality, safety or efficacy of a CTGT product, if —
(a)
that disclosure is, in the opinion of the Authority, necessary to protect the health or safety of members of the public; or
(b)
that disclosure is to a Government department or statutory body in order to enable the Government department or statutory body to perform its public functions.